The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer
Clinical trial NCT00171314 · COMPLETED
Trial details
- NCT number
- NCT00171314
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2010-11-01
- Enrollment
- 527
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.